This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Protalix Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Maor Sheva: Innovator in Nucleic Acid Constructs
Introduction
Maor Sheva is a notable inventor based in Kfar-Vradim, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid constructs. His innovative work has led to the development of methods that enhance the transformation of cells.
Latest Patents
Maor Sheva holds 1 patent for his invention titled "Removal of constructs from transformed cells." This patent discloses a nucleic acid construct that is removable after transformation, along with methods for utilizing the construct effectively. His work in this area has the potential to advance genetic engineering and therapeutic applications.
Career Highlights
Maor Sheva is currently employed at Protalix Ltd., a company known for its pioneering work in biopharmaceuticals. His role at Protalix Ltd. allows him to further explore and develop his innovative ideas in the biotechnology sector.
Collaborations
Maor collaborates with Uri Hanania, a fellow innovator in the field. Their partnership exemplifies the collaborative spirit that drives advancements in biotechnology.
Conclusion
Maor Sheva's contributions to the field of nucleic acid constructs highlight his role as an influential inventor. His work not only showcases his innovative spirit but also has the potential to impact the future of biotechnology significantly.
